STOCK TITAN

Aimei Health (NASDAQ: AFJK) adds one-month SPAC extension via $34K note

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd extended the deadline to complete its initial business combination by one month, moving the Termination Date from April 6, 2026 to May 6, 2026. To fund this seventeenth extension, the company deposited $34,330.96 into its trust account, equal to the lesser of $80,000 for all outstanding public shares or $0.033 per share for the month.

The extension payment was funded through an unsecured promissory note issued on April 7, 2026 to Aimei Health Ltd and United Hydrogen Group Inc., each providing $17,165.48. The note is non‑interest‑bearing and becomes due when Aimei completes a business combination with United Hydrogen. The payees may instead convert the note into private units at $10.00 per unit, each unit consisting of one ordinary share and a right to receive one‑fifth of one ordinary share.

Positive

  • None.

Negative

  • None.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Extension payment $34,330.96 Deposited into trust account for one-month extension
Per-share monthly extension cost $0.033 per public share Monthly extension amount per outstanding public share
Alternative extension cap $80,000 Lessor-of cap for all outstanding public shares per month
Contribution per payee $17,165.48 Amount funded by each of Aimei Health Ltd and United Hydrogen
New Termination Date May 6, 2026 Extended deadline to consummate initial business combination
Conversion price per unit $10.00 per unit Price to convert promissory note into private units
Number of extensions 17th extension Seventeenth extension under Articles of Association
trust account financial
"has been deposited into the trust account of Aimei Health Technology Co., Ltd"
A trust account is a special bank or brokerage account where assets are held and managed by a designated person or firm (the trustee) for the benefit of another person or group (the beneficiary). It matters to investors because it separates assets from personal or corporate funds, can protect assets, control how and when money is used, and may affect tax or legal rights—think of it as a locked drawer opened only under agreed rules.
initial business combination financial
"extend the period of time it has to consummate its initial business combination by one month"
An initial business combination is the deal in which a special-purpose acquisition company (SPAC) merges with or acquires an operating business to bring that business onto public markets. Think of the SPAC as an empty shell that raises money from investors, then uses that cash to buy a private company—this transaction turns the private company into a public one and often changes its ownership, valuation, and access to capital, so investors should watch for shifts in risk, future growth prospects, and shareholder rights.
Termination Date regulatory
"from April 6, 2026 to May 6, 2026 (the “Termination Date”)"
Termination date is the specific calendar day when a contract, agreement, option or other legal arrangement stops being in effect and any remaining rights or obligations expire. For investors it matters because that date sets deadlines for exercising rights, receiving payments, closing positions or avoiding penalties—similar to the day a lease or warranty ends, after which parties no longer have the same protections or claims.
Promissory Note financial
"an unsecured promissory note in the total principal amount of $34,330.96 (the “Promissory Note”)"
A promissory note is a written IOU in which one party promises to pay a specific sum, often with interest, to another party by a set date or on demand. Investors care because it functions like a loan: it creates a legal claim on future cash flows, carries credit and timing risk, and can affect valuation or liquidity—think of it as a formal, tradable promise to be repaid that can be assessed like any other debt investment.
private units financial
"convert the Promissory Note, in whole or in part, into private units of the Company"
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
false 0001979005 0001979005 2026-04-07 2026-04-07 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2026-04-07 2026-04-07 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2026-04-07 2026-04-07 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-04-07 2026-04-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

April 7, 2026

Date of Report (Date of earliest event reported)

 

AIMEI HEALTH TECHNOLOGY CO., LTD

(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands   001-41880   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

10 East 53rd Street, Suite 3001

New York, NY

  10022
(Address of Principal Executive Offices)   (Zip Code)

 

86-13758131392

Registrant’s telephone number, including area code

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol(s)   Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share   AFJK   The Nasdaq Stock Market LLC
Rights, exchangeable into one-fifth of one Ordinary Share   AFJKR   The Nasdaq Stock Market LLC
Units, each consisting of one Ordinary Share and one Right   AFJKU   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

 

Extension of the Termination Date

 

An aggregate of $34,330.96 (the “Extension Payment”) has been deposited into the trust account of Aimei Health Technology Co., Ltd (the “Company”) for its public shareholders, representing the lessor of (i) $80,000 for all outstanding public shares and (ii) $0.033 for each outstanding public share for each monthly extension, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from April 6, 2026 to May 6, 2026 (the “Termination Date”). The Extension is the seventeenth extension permitted under the Amended and Restated Articles of Association of the Company currently in effect.

 

Promissory Note

 

In connection with the Extension, the Company issued, on April 7, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “Promissory Note”) to Aimei Health Ltd, a Cayman Islands exempted company (the “Sponsor”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen,” and together with the Sponsor, the “Payees”). The amount was equally divided between the Payees, with each contributing $17,165.48, to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “Business Combination”). The Payees have the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notices of their intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination.

 

The foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

 

Item 9.01 Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
10.1   Promissory Note, dated April 7, 2026, by and among Aimei Health Technology Co., Ltd, Aimei Health Ltd, and United Hydrogen Group Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 7, 2026

 

  Aimei Health Technology Co., Ltd
        
  By: /s/ Junheng Xie
  Name: Junheng Xie
  Title: Chief Executive Officer and Director
    (Principal Executive Officer)

 

 

FAQ

What did Aimei Health Technology (AFJK) announce in this 8-K filing?

Aimei Health Technology disclosed a one-month extension of its business combination deadline to May 6, 2026. It deposited $34,330.96 into its trust account, funded by a new non‑interest‑bearing promissory note issued to its sponsor and United Hydrogen Group Inc.

How is Aimei Health (AFJK) funding the latest extension of its SPAC deadline?

The company funded the extension with an $34,330.96 deposit into its trust account. This amount came from an unsecured promissory note issued on April 7, 2026 to Aimei Health Ltd and United Hydrogen Group Inc., each contributing $17,165.48.

What are the key terms of Aimei Health’s new promissory note?

The promissory note totals $34,330.96, bears no interest, and becomes due when Aimei completes a business combination with United Hydrogen. The payees can instead convert the note into private units at $10.00 per unit immediately prior to closing, if they give proper notice.

How many times has Aimei Health extended its business combination deadline?

The company stated this is its seventeenth extension under its Amended and Restated Articles of Association. Each extension allows additional time to complete an initial business combination while requiring a corresponding cash contribution into the trust account for public shareholders.

What does each private unit of Aimei Health consist of upon conversion?

Each private unit consists of one ordinary share and a right to receive one‑fifth of one ordinary share. The promissory note allows the payees to convert outstanding principal into these units at $10.00 per unit immediately before the business combination with United Hydrogen closes.

Filing Exhibits & Attachments

5 documents